324 results on '"Sokoloff, Pierre"'
Search Results
2. A Historical Perspective on the Dopamine D3 Receptor
3. A Historical Perspective on the Dopamine D3 Receptor
4. Binding of the D3-preferring antipsychotic candidate F17464 to dopamine D3 and D2 receptors: a PET study in healthy subjects with [11C]-(+)-PHNO
5. Chapitre 10 : La dépression et ses traitements
6. Randomized, double-blind, placebo-controlled study of F17464, a preferential D3 antagonist, in the treatment of acute exacerbation of schizophrenia
7. Dopamine receptors in GtoPdb v.2023.1
8. Induction of Dopamine D 3 Receptor Expression as a Mechanism of Behavioral Sensitization to Levodopa
9. FLT3 signaling inhibition preserves opioid analgesia while abrogating tolerance and hyperalgesia
10. Dopamine receptors: structure, function and implication in psychiatric disorders
11. BDNF-Dependent Behavioral Sensitization in Hemiparkinsonian Rats
12. High-Throughput Screening for Extracellular Inhibitors of the FLT3 Receptor Tyrosine Kinase Reveals Chemically Diverse and Druggable Negative Allosteric Modulators
13. A Functional Variant of the Dopamine D₃ Receptor Is Associated with Risk and Age-at-Onset of Essential Tremor
14. A Paradoxical Regulation of the Dopamine D 3 Receptor Expression Suggests the Involvement of an Anterograde Factor from Dopamine Neurons
15. Identification, Characterization, and Localization of the Dopamine D 3 Receptor in Rat Brain Using 7-[ 3 H]hydroxy-N,N-di-n-Propyl-2- Aminotetralin
16. Widespread Distribution of Brain Dopamine Receptors Evidenced with [$^{125}$I]Iodosulpride, a Highly Selective Ligand
17. Direct and indirect interactions of the dopamine D3 receptor with glutamate pathways: implications for the treatment of schizophrenia
18. Dopamine D3 receptor ligands for drug addiction treatment
19. Effects of dimethylaminoethanol pyroglutamate (DMAE p-Glu) against memory deficits induced by scopolamine: evidence from preclinical and clinical studies
20. Chapter 29 Synaptic and Nuclear Localizations of the G Protein-Coupled Receptor GPR88
21. Pharmacology profile of F17464, a dopamine D3 receptor preferential antagonist
22. Dopamine D3 receptor ligands modulate the acquisition of morphine-conditioned place preference
23. Dopamine and glutamate dysfunctions in schizophrenia: Role of the dopamine D3 receptor
24. Distribution and Regulation of the G Protein- Coupled Receptor Gpr88 in the Striatum: Relevance to Parkinson’s Disease
25. Brain-derived neurotrophic factor controls dopamine D3 receptor expression: Implications for neurodevelopmental psychiatric disorders
26. Attenuation of levodopa-induced dyskinesia by normalizing dopamine D3 receptor function
27. The dopamine D3 receptor and drug addiction
28. BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization
29. New therapeutic targets to develop molecules active in drug-resistant epilepsies
30. Striatal GPR88 expression is confined to the whole projection neuron population and is regulated by dopaminergic and glutamatergic afferents
31. Pathogenesis of levodopa-induced dyskinesia: focus on D1 and D3 dopamine receptors
32. Modelling Parkinson-like neurodegeneration via osmotic minipump delivery of MPTP and probenecid
33. Autoradiographic localisation of D3-dopamine receptors in the human brain using the selective D3-dopamine receptor agonist (+)-[3H]PD 128907
34. BDNF-Dependent Behavioral Sensitization in Hemiparkinsonian Rats
35. Induction of dopamine D3 receptor expression as a mechanism of behavioral sensitization to levodopa
36. The dopamine D3 receptor and drug dependence: Effects on reward or beyond?
37. Neuroadaptations to hyperdopaminergia in dopamine D3 receptor-deficient mice
38. Novel dopamine receptors half a decade later
39. A paradoxical regulation of the dopamine D3 receptor expression suggests the involvement of an anterograde factor from dopamine neurons
40. Brain-derived neurotrophic factor controls dopamine D3 receptor expression: therapeutic implications in Parkinsonʼs disease
41. The dopamine D3 receptor mediates locomotor hyperactivity induced by NMDA receptor blockade
42. Role of the dopamine D3 receptor in reactivity to cocaine-associated cues in mice
43. Identification, characterization, and localization of the dopamine D3 receptor in rat brain using 7-(3H)hydroxy-N,N-di-n-propyl-2-aminotetralin
44. The dopamine D 3 receptor mediates locomotor hyperactivity induced by NMDA receptor blockade
45. Dopamine activation of the arachidonic acid cascade as a basis for D1/D2 receptor synergism
46. Selective inhibition of cocaine-seeking behaviour by a partial dopamine D3 receptor agonist
47. Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuropeptides
48. Inhibition of neuronal FLT3 receptor tyrosine kinase alleviates peripheral neuropathic pain in mice
49. Binding of the D3-preferring antipsychotic candidate F17464 to dopamine D3 and D2 receptors: a PET study in healthy subjects with [11C]-(+)-PHNO
50. Dopamine receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.